Actelion (now Janssen Pulmonary Hypertension)

Switzerland · 780 Employees
Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs.

概述

国家 Switzerland
成立时间 1997
总部 Basel
电话号码 +41-61-565-6565
网站
LinkedIn http://www.linkedin.com/company/actelion-'now-janssen-pulmonary-hypertension'
Twitter http://www.twitter.com/actelion_com
Facebook http://www.facebook.com/actelion
员工数 780
行业 pharmaceuticals,
简介 Actelion is a bio-technology firm that discovers, develops and commercializes drugs for unmet medical needs.

常见问题

Actelion (now Janssen Pulmonary Hypertension) 在哪里?

Actelion (now Janssen Pulmonary Hypertension) 的总部位于 Basel

Actelion (now Janssen Pulmonary Hypertension) 的电话号码是多少?

Actelion (now Janssen Pulmonary Hypertension) 的电话号码是 +41-61-565-6565

Actelion (now Janssen Pulmonary Hypertension) 的官方网站是什么?

Actelion (now Janssen Pulmonary Hypertension) 的公司官方网站是

Actelion (now Janssen Pulmonary Hypertension) 是做什么的?

Actelion (now Janssen Pulmonary Hypertension) 的业务有哪些?

biotechnology,life sciences

Actelion (now Janssen Pulmonary Hypertension) 的年收入是多少?

Actelion (now Janssen Pulmonary Hypertension) 的收入是 2400000000美元

Actelion (now Janssen Pulmonary Hypertension) 有多少员工?

Actelion (now Janssen Pulmonary Hypertension) 有 780 名员工

Actelion (now Janssen Pulmonary Hypertension) 属于哪个行业?

Actelion (now Janssen Pulmonary Hypertension) 从事以下行业: pharmaceuticals

Actelion (now Janssen Pulmonary Hypertension) 使用什么技术?

Actelion (now Janssen Pulmonary Hypertension) 使用的一些流行技术包括:

如何联系 Actelion (now Janssen Pulmonary Hypertension)?

Actelion (now Janssen Pulmonary Hypertension) 联系信息: 电话号码:+41-61-565-6565, 网站:, 邮箱:ema***@***.com

Actelion (now Janssen Pulmonary Hypertension) 的社交媒体链接是什么?

Actelion (now Janssen Pulmonary Hypertension) 领英:http://www.linkedin.com/company/actelion-'now-janssen-pulmonary-hypertension',fackbook:http://www.facebook.com/actelion,twitte:http://www.twitter.com/actelion_com

Actelion (now Janssen Pulmonary Hypertension) 是一家上市公司吗?

是的,Actelion (now Janssen Pulmonary Hypertension)是一家上市公司,在six公开挂牌上市,上市交易代码:ATLN

Actelion (now Janssen Pulmonary Hypertension) 的最后一轮融资是什么时候?

暂无最近投资信息

谁投资 Actelion (now Janssen Pulmonary Hypertension)?

Actelion (now Janssen Pulmonary Hypertension) 有 0 家投资者,包括 。

管理层

James Heuck

Training Manager, Therapy Access

Pascal Haas

Global Trial Manager

Erika Pierce

Key Account Manager

员工

Solenn Salaun

Project Management Services Team Leader

Carole Eustache

Responsable Parcours Patient

Josephine Pidcock

EDMS Change Management Coordinator

外贸获客 查找关键决策人

10亿+海关交易数据,1.2亿企业数据,2亿+企业联系人数据,1000千万真实采购商。覆盖200+个国家及地区,95%外贸重点拓展市场,可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少,成就更大,销售更聪明

查找更多 B2B 联系人,丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google